Skip to main content
. 2019 Feb 22;26(3):309–318. doi: 10.1002/cpp.2352

Table 1.

Demographical and clinical characteristics of MBCT patients (n = 120)

Completer (n = 84) Decliner/dropout (n = 36) Test statistic (t or χ 2) p
Sociodemographic Age M (SD) Years 52.6 (10.7) 49.2 (11.9) 1.5 0.127
Gender n (%) Female 70 (83.3) 31 (86.1) 1.5 0.702
Educational level n (%) Secondary 25 (29.8) 10 (27.3) 0.48 0.827
Vocational/university 59 (70.2) 26 (72.7)
Clinical Cancer diagnosis n (%) Breast 54 (64.3) 21 (58.3) 0.38 0.537
Prostate 7 (8.3) 1 (2.8)
Colon 5 (6.0) 3 (8.3)
Gyn. 4 (4.8) 1 (2.8)
Non‐Hodgkin 2 (2.4) 3 (8.3)
Other 12 (14.3) 7 (19.4)
Time since diagnosis M (SD) Years 3.7 (5.3) 3.0 (4.1) 0.67 0.506
Cancer treatment intent n (%) Curative 74 (88.1) 30 (83.3) 0.5 0.482
Current anticancer treatment n (%) Yes 41 (48.8) 15 (41.7) 0.52 0.472
Treatment outcome Psychological distress M (SD) HADS 18.3 (6.5) 18.0 (7.0) 0.22 0.826
Process factor Therapeutic alliance M (SD) WAI 39.1 (8.8)
Group cohesion M (SD) GCQ 95.3 (11.3)

Note. GCQ: Group Cohesion Questionnaire; HADS: Hospital Anxiety and Depression Scale; MBCT: mindfulness‐based cognitive therapy; WAI: Working Alliance Inventory.